TECH · EST. 2017

MediCloud Biotech

采曜生醫科技
Related PatientsForce service

The group’s health-tech R&D engine: an in-house team building the digital and quantitative infrastructure of PAP/PSP. Sharing the patient-support domain with Health Strategies, it differentiates on proprietary platforms, data and automation — flagship MediPASS won the 2021 National Healthcare Quality Award. Likewise certified to SGS ISO 9001, 27001 and 27701.

2021Quality Award
6Proprietary platforms
ISO certifications
ADVISORY SOLUTIONS · 專業顧問解決方案
  • Proprietary platform R&D (Medi family)R&D

    In-house product and engineering teams building the six Medi platforms — composed and iterated per scenario.

  • Digital PAP/PSP infrastructurePASS

    Enrollment-to-reconciliation digitization: compliant donation management, pharmacy e-sign and GDP document flows (MediPASS).

  • Quantified outcomes & analyticsDATA

    Live dashboards, digital footprints and quantified outcome metrics driving program decisions and HCP engagement (MediKNOW).

CONSULTING APPROACH · 顧問服務方法
01
Diagnose

Map journey gaps & compliance risk

02
Design

Evidence- and regulation-led solutions

03
Deploy

Platforms, expert teams & SOPs live

04
Measure

Outcome reporting & iteration

MediCloud Biotech — Our Companies | Media-WIND Health Holdings